Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GPB Capital Holdings was a New York-based private equity firm, founded in 2013, focused on acquiring middle-market companies across various sectors, including healthcare, automotive, and waste management. It raised over $1.8 billion from investors but ceased operations after its founder and CEO were convicted of fraud in a Ponzi-like scheme. The firm is currently in receivership, with asset sales underway to repay defrauded investors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GPB Holdings.